12/30/2025
Update on Ophirex/Varespaldib oral snake bite study.
Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment Corte Madera, Calif., December 11, 2025 Company announces agreement with FDA on human approval pathway based on Animal Rule Varespladib has received FDA MU...